Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-15

FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Nortriptyline Hydrochloride from Teva Pharmaceuticals USA, Inc., updating or expanding the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nortriptyline Hydrochloride (Nortriptyline hydrochloride)

Snippet

SUPPL AP for NORTRIPTYLINE HYDROCHLORIDE (NORTRIPTYLINE HYDROCHLORIDE)